The concept of IL-2/IL-2R complex-mediated Treg approach represents a novel stroke treatment in that it affords a wider therapeutic window, recapitulates a pharmacologic ligand–receptor interaction, and acts by regulating the inflammation-plagued secondary cell death (Zhang et al., 2018). The gene discussed is IL2RA; the disease is stroke disorder.